Phase II study of antineoplastons A10 and AS2-1 in adult patients with anaplastic astrocytoma
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Anaplastic astrocytoma
- Focus Therapeutic Use
- Sponsors Burzynski Research Institute
- 25 Oct 2016 Status changed from recruiting to completed.
- 18 Jun 2015 Results in recurrent anaplastic astrocytoma patients published in Cancer and Clinical Oncology, according to a Burzynski Research Institute media release.
- 18 Jun 2015 Results published in the Media Release.